Back

Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells

Kuo, Y.-Y.; Chen, W.-T.; Lin, G.-B.; Lu, C.-H.; Chao, C.-Y.

2022-05-02 cancer biology
10.1101/2021.11.19.469215 bioRxiv
Show abstract

BackgroundPancreatic cancer is a deadly cancer around the world. To reduce side effects and enhance treatment efficacy, study on combination therapy for pancreatic cancer has gained much attention in recent years. MethodsIn this paper, we propose a novel triple treatment combining propolis and two physical stimuli-thermal cycling-hyperthermia (TC-HT) and low-intensity ultrasound (US) on a human pancreatic cancer cell line PANC-1. MTT assay was used to determine the viability of PANC-1 cells. Flow cytometry was used to detect apoptosis, mitochondrial membrane potential (MMP) loss, and intracellular reactive oxygen species (ROS) levels. Western blot analysis was further performed to measure protein expression and phosphorylation. ResultsThe experiments found that, after the triple treatment, the cell viability of the PANC-1 cells decreased to a level 80% less than the control, without affecting the normal pancreatic cells. Another result was excessive accumulation of ROS after the triple treatment, leading to the amplification of apoptotic pathway through the mitogen-activated protein kinase (MAPK) family and mitochondrial dysfunction. Moreover, the combination of TC-HT and US also promotes the anticancer effect of the heat-sensitive chemotherapy drug cisplatin on PANC-1 cells. ConclusionThis study, to the best of our knowledge, is the first attempt to combine TC-HT, US and a nature compound in cancer treatment. We demonstrate that physical stimuli could augment the therapeutical effect of anticancer agents. It is expected that optimized parameters for different agents and different types of cancer will expand the methodology on oncological therapy in a safe manner.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 14%
13.1%
2
Scientific Reports
3612 papers in training set
Top 3%
11.6%
3
Biochemistry and Biophysics Reports
30 papers in training set
Top 0.1%
10.1%
4
Ultrasound in Medicine & Biology
10 papers in training set
Top 0.1%
3.7%
5
Frontiers in Oncology
103 papers in training set
Top 1%
2.9%
6
International Journal of Molecular Sciences
494 papers in training set
Top 4%
2.9%
7
Cancers
213 papers in training set
Top 2%
2.5%
8
RSC Advances
22 papers in training set
Top 0.2%
2.5%
9
Chemical Research in Toxicology
10 papers in training set
Top 0.1%
2.2%
50% of probability mass above
10
PeerJ
308 papers in training set
Top 4%
2.0%
11
Heliyon
152 papers in training set
Top 3%
2.0%
12
Advanced Biology
29 papers in training set
Top 0.2%
1.8%
13
eLife
5828 papers in training set
Top 48%
1.8%
14
Molecules
39 papers in training set
Top 0.7%
1.6%
15
Bioactive Materials
20 papers in training set
Top 0.4%
1.4%
16
ACS Omega
105 papers in training set
Top 2%
1.4%
17
Advanced Science
286 papers in training set
Top 6%
1.4%
18
Biomedicine & Pharmacotherapy
42 papers in training set
Top 0.8%
1.2%
19
Cells
249 papers in training set
Top 4%
1.2%
20
Journal of Translational Medicine
57 papers in training set
Top 1%
1.1%
21
Theranostics
37 papers in training set
Top 0.8%
1.1%
22
iScience
1154 papers in training set
Top 33%
0.9%
23
Applied Sciences
25 papers in training set
Top 0.7%
0.9%
24
Aging
75 papers in training set
Top 2%
0.9%
25
Oncotarget
18 papers in training set
Top 0.5%
0.6%
26
Cancer Medicine
26 papers in training set
Top 1%
0.6%
27
Biomedicines
67 papers in training set
Top 3%
0.6%
28
Pharmaceuticals
34 papers in training set
Top 1%
0.6%
29
Journal of Advanced Research
14 papers in training set
Top 0.3%
0.6%
30
International Journal of Biological Macromolecules
76 papers in training set
Top 2%
0.6%